Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Sept 2026 for NEKTAR THERAPEUTICS. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
R. Scott Greer: trading record in brief
R. Scott Greer (board member) discloses dealings in 3 companies, chiefly Nektar Therapeutics, Inogen Inc and Stemcells Inc. In total, 7 filings cover trades dated from 1 January 2016 to 23 September 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 25 September 2026, the filings show a share grant in Nektar Therapeutics. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to R. Scott Greer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
2,000 shares0Common StockSEC:0001193125-26-403103:0
10,200 shares0Common StockSEC:0001209191-22-050815:0
12,500 shares@ US$12.8022.2% of flowCommon StockSEC:0001209191-21-063656:0
10,200 shares0Common StockSEC:0001209191-21-057707:0
45,000 shares@ US$12.7077.8% of flowCommon StockSEC:0001209191-21-054136:0
2,754 shares0Common StockSEC:0001209191-21-032218:0
146,342 sharesCommon StockSEC:0001209191-16-088777:0
7 of 7 declarations
